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Abstract
Effective control of the intracellular protozoan parasite Toxoplasma gondii depends on the activation of antigen-specific
CD8
+ T-cells that manage acute disease and prevent recrudescence during chronic infection. T-cell activation in turn,
requires presentation of parasite antigens by MHC-I molecules on the surface of antigen presenting cells. CD8
+ T-cell
epitopes have been defined for several T. gondii proteins, but it is unclear how these antigens enter into the presentation
pathway. We have exploited the well-characterized model antigen ovalbumin (OVA) to investigate the ability of parasite
proteins to enter the MHC-I presentation pathway, by engineering recombinant expression in various organelles. CD8
+ T-
cell activation was assayed using ‘B3Z’ reporter cells in vitro, or adoptively-transferred OVA-specific ‘OT-I’ CD8
+ T-cells in vivo.
As expected, OVA secreted into the parasitophorous vacuole strongly stimulated antigen-presenting cells. Lower levels of
activation were observed using glycophosphatidyl inositol (GPI) anchored OVA associated with (or shed from) the parasite
surface. Little CD8
+ T-cell activation was detected using parasites expressing intracellular OVA in the cytosol, mitochondrion,
or inner membrane complex (IMC). These results indicate that effective presentation of parasite proteins to CD8
+ T-cells is a
consequence of active protein secretion by T. gondii and escape from the parasitophorous vacuole, rather than degradation
of phagocytosed parasites or parasite products.
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Introduction
Class I Major Histocompatability Complex (MHC-I) molecules
present peptides generated by proteasomal degradation in the
cytosol and transport into the endoplasmic reticulum, or by cross-
presentation of endo/phagocytosed material [1,2]. During infec-
tion, MHC-I antigen presentation is responsible for the activation
and expansion of specific CD8
+ T-cells, and is involved in the
immune response to diverse intracellular pathogens, including
viruses, bacteria, and microbial eukaryotes [3,4]. CD8
+ T-cells are
required for the control of the protozoan parasite Toxoplasma gondii
during its acutely lytic ‘tachyzoite’ stage, and (directly or indirectly)
during the chronic ‘bradyzoite’ stage characterized by latent cysts in
themuscle, brainand othertissues[5,6]. Activated T-cellsrecognize
and destroy both T. gondii parasites and parasite-infected cells, and
also produce IFN-c, activating reactive oxygen pathways [7–9].
The route by which T. gondii antigens reach the endoplasmic
reticulum for loading onto MHC-I is not fully understood, as these
parasites reside within a specialized intracellular ‘parasitophorous
vacuole’ (PV) distinct from the phagocytic/endocytic pathway and
the host cell cytoplasm. Presentation is dependent on host cell
immunoproteasomes, TAP, and ERAAP [10–12], indicating that
parasite antigens must reach the host cell cytosol, and several
pathways have been proposed, including cross-presentation of
phagocytosed parasite material, degradation of the PV membrane,
secretion of parasite proteins outside of the PV, and fusion of the
PV with the host cell ER [13–15]. Various immunogenic T. gondii
antigens are known, including proteins secreted from the dense
granules and rhoptries, but responses are often both parasite and
host strain-specific [9,12,16,17]. In order to address the route of T.
gondii antigen entry into the MHC-I presentation pathway, we
have examined CD8
+ T-cell activation following infection with
parasites engineered to target the well-characterized antigen
ovalbumin to various locations, including the parasite cytoplasm,
mitochondrion, inner membrane complex, plasma membrane,
and the parasitophorous vacuolar space.
Results
Generation of transgenic parasite expressing organelle
specific OVA antigen
To explore whether antigen access to the MHC-I presentation
pathway is affected by subcellular location of antigen within T.
gondii, RH strainT.gondiiwasengineered to stablyexpress the model
antigen OVA (amino acids 140–386), fused to various organelle-
targeting sequences as described under Methods. The rationale
behind these experiments was to help distinguish between cross-
presentation of phagocytosed antigen, versus translocation of antigen
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parasites reside (a compartment distinct from the endophagocytic
system; [18]). As shown in Fig. 1A (top row), expression of
ovalbumin without additional targeting signals results in cytoplas-
mic localization (Cyto-OVA), while fusion to a signal sequence
results in secretion into the parasitophorous vacuole (P30-OVA), as
previously described by Pepper et al [19]. Co-localization of
additional OVA fusion proteins with well-characterized markers
showed proper targeting to the inner membrane complex (IMC-
OVA, row 2), the mitochondrion (HSP-OVA, row 3), or the cell
surface, using a GPI anchor (GPI-OVA, row 4). Antibodies to OVA
label the surface of non-permeabilized, extracellular GPI-OVA
parasites, indicating targeting to the parasite membrane (row 4);
permeabilization prior to staining also reveals OVA associated with
internal secretory organelles (ER, Golgi, vesicles), presumably en
route to the plasma membrane (row 5).
As antigen load is known to be important during infection [20],
OVA levels were assessed by immunoblotting of parasites (Fig. 1B)
and infected culture supernatants (Fig. 1C). Levels of OVA
produced by individual parasite strains ranged from 4.5 to 21 ng/
10
6 parasites. Secreted antigen was detected only in P30-OVA and
GPI-OVA culture supernatants (Fig. 1C). We presume that
significant quantities of GPI-OVA protein are shed from the
parasite surface during parasite gliding motility, as has been
reported for the endogenous P30 protein [21]. No secreted antigen
was detected in culture supernatants following HSP-OVA or IMC-
OVA infection. Cyto-OVA was not included on this Western blot,
but no secreted OVA was detected in Pru Cyto-OVA transgenics
(not shown), and note that no secreted antigen is visible in Fig. 1A
(top left). In vitro assays indicate similar rates of replication for all of
the transgenics described in this report, and preliminary real-time
PCR analysis of liver and spleen samples from infected mice
indicates ,1.5-fold difference in parasite burden (data not shown).
Antigen presentation and T-cell activation in vitro
correlate with antigen secretion
The ability of OVA transgenic lines to induce MHC-I antigen
presentation in vitro was determined using the ‘B3Z’ CD8
+ T-cell
hybridoma line [22]. Recognition of the OVA antigenic epitope
‘SIINFEKL’ in the context of the H-2K
b restricted MHC-I mouse
background causes activation of these cells to produce ß-
galactosidase, which is readily detected by conversion of CPRG to
a purple reaction product. Activated (IFN-c treated) bone marrow-
derived macrophages were able to present antigen (activate B3Z
cells) when infected with T. gondii parasites secreting OVA (P30-
OVA and GPI-OVA transgenics), but not parasites harboring
intracellular OVA antigen (Cyto-OVA, HSP-OVA, IMC-OVA), as
shown in Fig. 2A. Significant activation was also seen in bone
marrow-derived dendritic cells following infection with P30-OVA
transgenics (Fig. 2B); an increase was observed in GPI-OVA-
infected dendritic cells as well, although this failed to achieve
statistical significance at P,0.05. The lower levels of activity
observed using GPI-OVA transgenics likely reflect the lower levels
of OVA secreted by this parasite line (Fig. 1C). T-cell activation was
strictly dependent on the presence of live T. gondii parasites: heat-
killed parasites were readily taken up by activated macrophages, but
these effectors failed to activate B3Z cells (data not shown).
Activation of naı ¨ve OT-I cells in vivo correlates with OVA
secretion
In order to determine whether the activation of B3Z T-cells by
T. gondii-expressed OVA antigen in vitro reflects T-cell activation in
vivo, non-activated OVA specific CD8
+ T-cells (OT-I cells) were
labeled with carboxy-fluoresceine succinimidyl ester (CFSE) and
transferred into naı ¨ve mice. Five days after infection with T. gondii
transgenics expressing OVA or wild-type controls, cells from the
peritoneum, parathymic lymph node, and spleen were assayed for
CFSE dilution and T-cell activation markers, as shown in Figure 3.
OT-I cells from uninfected animals, or mice infected with wild-
type RH strain T. gondii, showed no diminution of CFSE levels,
indicating that the T-cells were not activated by parasite infection
per se over the course of this experiment (Fig. 3A, light shading). All
mice infected with either of the parasite lines secreting OVA (P30-
OVA, GPI-OVA) displayed marked dilution of CFSE (Fig. 3A
upper left, intermediate and dark shading). The kinetics of CFSE
dilution in P30-OVA and GPI-OVA differed, however (Fig. 3A,
right-hand panels): P30-OVA parasites activated T-cell prolifer-
ation as early as 3 days post-infection in all three compartments
(peritoneal exudate (PECs), lymph node, spleen), and by day 4
essentially all OT-I cells displayed reduced CFSE levels. In
contrast, T-cell activation by GPI-OVA parasites was first
observed at day 4 and while all OT-I cells had divided by day
5, CFSE dilution still lagged slightly behind that observed
following P30-OVA parasite infection (upper left). This delay
likely reflects slower accumulation of antigen due the slow release
of GPI-anchored OVA from the parasite cell surface. Further
indication of OT-I cell activation during infection is provided by
the down-regulation of CD62L and up-regulation of CD44
(Fig. 3B) and CD69 (not shown). Time-course assays indicate
similar kinetics of OT-I cell activation, whether measured by
CFSE dilution or activation markers (compare the right-hand
panels of Fig. 3A with Fig. 3B). Note that while mean fluorescence
levels shows a significant lag in CD44 up-regulation by GPI-OVA
parasites (Fig. 3B, bottom right), the histogram (bottom left)
indicates that the spectrum of CD44 expression in the GPI-OVA
sample is closer to the P30-OVA sample than the wild-type
control.
In contrast to the B3Z assay (Fig. 2), which showed no
detectable activation of T-cells by intracellular OVA, the more
sensitive in vivo system shows low levels of OT-I cell activation by
these parasites (Fig. 3A, lower left). At 5 days post infection, 50%
of OT-I cells showed a history of proliferation in the IMC-OVA
sample, based on reduced CFSE levels (note, however that this
reflects proliferation of ,50% of the starting population, as cell
numbers double with each division). These proliferating cells also
displayed up-regulation of CD44 and CD69, and lower levels of
surface CD62L (not shown). 30% of OT-I cells in the HSP-OVA
sample showed evidence of proliferation, while 15% showed
evidence of proliferation in response to Cyto-OVA; proliferation
was observed in only 9% of OT-I cells in response to wild-type
parasite infection. These results confirm that T. gondii antigens
secreted into the parasitophorous vacuole are readily presented on
MHC-I. Intracellular antigens are far less prone to MHC-I
presentation (and may derive from phagocytosis and cross-
presentation of dead parasites and parasite debris; see below for
further discussion).
Discussion
Activation of CD8
+ T-cells is known to be critical for the control
of T. gondii infection [5,23]. In order to further clarify the basis of
MHC-I antigen presentation during infection, OVA was expressed
in various subcellular compartments (Fig. 1), including three
locales within the parasite (the cytoplasm, inner membrane
complex, and mitochondrion) and two external locales (anchored
to the plasma membrane via a GPI anchor, and secreted into the
parasitophorous vacuole). Efforts to stably express OVA antigen in
Presentation of T. gondii Antigens on MHC-I
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while we (and others) have successfully targeted various reporters
into these organelles in transient transfectants, stable transgenics
are often more difficult to obtain, and these proteins typically fail
to secrete [24]. Our results demonstrate that subcellular
localization of antigen matters: surface and secreted antigen is
readily presented, while internal antigen is not (Figs. 2 & 3). While
surface antigens may be released at low levels from parasites prior
to invasion by either dense granule secretion or protein shedding
[21,25,26], the failure to present OVA from internal compart-
ments, and the requirement for living parasites, indicates that
biologically relevant antigen loading occurs only during active
infection, rather than by phagocytosis of parasites or parasite
debris from lysed host cells. These results support previous
observations with parasites secreting OVA or b-galactosidase
[11,27,28], although evidence for cross-presentation by uninfected
dendritic cells has also been reported during Prugniaud P30-OVA
infection [13].
Activation of OT-I cells induced by presentation of OVA
antigen secreted into the parasitophorous vacuole occurs as early
as day 3 post-infection. These data are consistent with previous
reports that CD8 responses against pathogens (including T. gondii)
are initiated within 3 days of infection [13,29]. By 5 days post-
infection, antigen-specific OT-I cells had proliferated extensively
Figure 1. Stable T. gondii parasite lines expressing transgenic OVA antigen. (A) OVA protein fused to endogenous targeting signals
correctly traffics OVA antigen (green) to specific organelles in T. gondii tachyzoites, including: the cytoplasm (row 1, left), the parasitophorous vacuole
(row 1, right), the inner membrane complex (row 2), the mitochondrion (row 3), and the parasite membrane (row 4). Permeabilization reveals
intracellular, as well as membrane-bound, GPI-OVA (row 5). Co-localization markers (red) include: anti-IMC1 antibody, mitotracker, and anti-P30
antibody, as labeled. Protein expression in stable transgenic parasites (B) and culture supernatants (C) was analyzed by immunblotting, using
antibodies directed against OVA and P30 (loading control).
doi:10.1371/journal.pone.0022936.g001
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were just getting underway (Fig. 3).
Although OVA is not a native parasite antigen, previous studies
have highlighted the importance of secreted T. gondii proteins in
CD8
+ T-cell responses to infection with various parasite strains
(P30/SAG1 [8,9,30], GRA6 [12], GRA4 & ROP7 [16], TGD057
[17]). In addition to secreted antigens, the observed CD8
+ T-cell
response to GPI-OVA, while slightly lower than responses to P30-
OVA (Fig. 3), suggests the possible importance of the large SAG/
SRS family [31] as subdominant epitopes in Toxoplasma infection.
These findings are also consistent with observations on other
intracellular pathogens: antigens secreted by either bacteria
(Listeria monocytogenes) or protozoa (Leishmania major, Trypanosoma
cruzi) are more effective in activating CD8
+ T-cells than
intracellular antigen [32–34]. In the Listeria system, it has also
been shown that T-cells stimulated by intracellular antigen are
limited in their ability to lyse infected cells, presumably because
intracellular antigens are unlikely to be presented by infected
target cells [32].
Both Listeria and T. cruzi live within the host cell cytoplasm, but
T. gondii is found within the ‘parasitophorous vacuole’, a
specialized intracellular compartment distinct from the endo-
phagocytic pathway [18]. The fact that secreted OVA is presented
by infected cells therefore implies that this antigen must escape
from the parasitophorous vacuole into the cytoplasm. The
mechanism by which OVA reaches the host cell cytoplasm is
uncertain, but there is ample precedent for traffic out of the
parasitophorous vacuole [11,35–37]. Previous studies have shown
that presentation of secreted OVA is dependent on TAP [11,27],
which mediates transport from the cytoplasm into the endoplasmic
reticulum [38]; additional work suggests that the parasitophorous
vacuole may sometimes fuse directly with the endoplasmic
reticulum [14]. Yet another possible model for antigen escape
from the parasitophorous vacuole involves vacuolar membrane
breakdown by IFN-c inducible p47 GTPase induced autophagic
mediated mechanisms releasing vacuolar proteins into the host cell
cytoplasm [15,39].
The use of antigen-specific reagents, including endogenous T-
cell tetramers and T-cell specific mice [12,16,17,40] should
provide answers to questions that have been difficult to interpret
using model antigen systems, including: the differences in T-cell
responses to multiple T. gondii strains, the role of changing antigen
availability during parasite differentiation, and the generation of
memory precursors. It will still be necessary to examine each
antigen individually, however, as different antigens can yield
different T-cells responses, based not only on their protein
sequence but also subcellular location, perhaps influencing the
clonality of the immune response. Further studies will be necessary
to understand how secreted antigens become accessible to the
MHC-I pathway, despite their apparent confinement to the
parasitophorous vacuole, and such work is likely to offer new
insights into the activation of CD8
+ T-cells during T. gondii
infection.
Materials and Methods
Ethics statement
Mouse studies were conducted in accord with all relevant
national and international guidelines, as approved by the
University of Pennsylvania Institutional Animal Care and Use
Committee (protocol 801344).
Parasites and cell cultures
RH DUPRT DHXPGRT strain T. gondii parasites were
maintained by serial passage in human foreskin fibroblast (HFF)
monolayers, cultivated in Eagle’s Minimal Essential Medium
(Gibco) containing 1% fetal bovine serum (FBS), as previously
described [41]. Extracellular tachyzoites were purified by filtration
through 3.0 mm filters (Nuclepore), and washed in phosphate
buffered saline.
Molecular methods
Expression vectors were based on the Bluescript pKS(+)-derived
plasmids tubP30OVAdhfr and tubCATOVAdhfr described previ-
ously by Pepper et al, in which the parasite’s major surface antigen
(P30, encoded by the SAG1 gene), lacking the C-terminal
glycophosphatidyl inositol (GPI) addition signal, is fused to amino
acids 140–386 of Gallus gallus ovalbumin (OVA) [19]. Transcrip-
tional regulatory sequences were provided by the T. gondii tubulin
1 promoter (tub) and dihydrofolate reductase 39 untranslated
region (dhfr). Plasmids employed in this report substituted the
following sequences in place of P30 (between tub and OVA,
flanked by Bgl II and Avr II sites): IMC1 (amino acids 1–608) for
targeting to the inner membrane complex [42], heat shock protein
60 (HSP 60) for mitochondrial targeting (amino acids 1–55) [43],
ROP1 for rhoptry targeting (amino acids 1–396) [44], or MIC3 for
microneme targeting (amino acids 1–358) [45]. Retention of P30-
Figure 2. Activation of OVA-specific B3Z T-cells by T. gondii
expressing OVA antigen. Bone marrow derived macrophages (A)
and dendritic cells (B) were stimulated with OT-I peptide or infected
with T. gondii expressing OVA in various subcellular compartments
(Fig. 1), and co-cultivated with B3Z T-cells in medium containing the ß-
galactosidase substrate CPRG. Absorbance at 565 nm is represented
relative to controls treated with media alone (average of three replicate
assays). Results shown are representative of three independent
experiments. Asterisks indicate p,0.05 (*) or p,0.005 (**), based on
the students T-test statistic.
doi:10.1371/journal.pone.0022936.g002
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GPI anchor motif (AAGTASHVSIFAMVIGLIGSIAACVA;
flanked by Nhe I and Afl II sites) to the C-terminus of OVA. All
plasmids also included a sagCATsag cassette downstream of the
OVA reporter gene for selecting stable transgenic parasites. 10
7
freshly harvested extracellular tachyzoites were transfected with
50 mg linearized plasmid DNA (2 mm gap cuvettes, 1.5 kEV
pulse, 24V), inoculated into HFF cell monolayers in 20 mM
chloramphenicol, and incubated through three passages prior to
cloning in 96 well plates by limiting dilution [46].
Immunofluorescence Assays and Microscopy
Confluent HFF monolayers grown on glass coverslips were
inoculated with clonal parasite lines expressing OVA, incubated
for various times, fixed in 4% formaldehyde (in PBS), permeabi-
lized in 0.2% TritonX-100, blocked in 10% fetal bovine serum,
and stained with rabbit anti-chicken ovalbumin (Bethyl Labora-
tories; Montgomery, Texas), followed by ALEXA 448-conjugated
goat anti-rabbit antibodies (Molecular Probes/Invitrogen), as
described previously [19]. For co-localization, parasites were
stained with mouse anti-P30 or anti-IMC1 (kindly provided by
Drs. David Sibley, Washington University School of Medicine,
and Gary Ward, University of Vermont, respectively), followed by
ALEXA 594-conjugated goat anti-mouse antibodies (Molecular
Probes/Invitrogen). Mitotracker was used for mitochondrial
detection, and 10 mM DAPI for nuclear labeling. Images were
captured using a Leica inverted epifluorescence microscope fitted
with a 100 W Hg lamp and appropriate filter sets.
Western Blots
Free T. gondii tachyzoites (2610
6) were filtered through a 3 mM
Nuclepore filter, pelleted by centrifugation, washed with PBS, and
treated 30 min with DNAse I (0.2 U/ml) at 37uC. Parasite samples
and OVA standards (Worthington Biochemical; Lakewood NJ),
Figure 3. Proliferation of adoptively transferred OT-I T-cells after infection with OVA-expressing T. gondii. (A) CFSE levels of Thy1.2+
OT-I T-cells after murine infection with T. gondii expressing secreted or GPI-anchored OVA (top left) or intracellular OVA antigens (bottom left). Right-
hand panels indicate the time course of OT-I activation in various organs (% CFSE-dull cells) following infection with P30-OVA or GPI-OVA. (B) CD62L
(top) and CD44 (bottom) levels on Thy1.2+ OT-I T-cells after mice were infected with T. gondii expressing either secreted or GPI-anchored OVA (left,
histograms; right, time course).
doi:10.1371/journal.pone.0022936.g003
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a 4–12% bis-tris gel (Nupage; Invitrogen) in MES, in parallel with
protein standards (MagicMark; Invitrogen), and transferred to
nitrocellulose membranes using a semi-dry system (BioRad). After
probing with rabbit anti-OVA (Bethyl Laboratories; 1:2000) or
anti-TgDHFR [47] and horseradish peroxidase-conjugated goat
anti-rabbit antibodies (Jackson ImmunoResearch; 1:3000), chemi-
luminescence was detected with Immobilon Chemiluminescent
HRP Substrate (Millipore; Billerica MA) and exposed to Kodak
MR X-ray film. OVA production levels were determined using a
standard curve generated from purified OVA dilutions run in
parallel with parasite samples, and analyzed using Image J
software.
B3Z assays
Macrophages (MØ) and dendritic cells (DC) were prepared as
described previously [48,49]. Briefly, bone marrow was extracted
from C57Bl/6 female mice, and cultivated 8–9 d in uncoated
plastic dishes containing RPMI medium, 10% FBS (Gibco), and
either 30% L929 culture supernatant (for MØs), or 20 ng/ml
GM-CSF (PeproTech, for DCs). Cells were inoculated into 96 well
flat bottom plates at 10
5 per well, incubated overnight at 37uC,
supplemented with medium +/2 recombinant mouse interferon-c
(100 U/ml), and incubated for 4 hr. Triplicate wells were
inoculated with live (MOI=0.5) or heat-killed (MOI=5) tachy-
zoites, recombinant OVA (500 mg/ml; Worthington, Lakewood
NJ), or OT-I peptide (50 ng/ml SIINFEKL; CHI Scientific,
Maynard MA), and incubated 12 hr in RPMI+10% FBS, followed
by the addition of B3Z T-cell hybridoma cells (10
5 / well), and a
12 hr further incubation in RPMI without phenol red. Finally,
cultures were supplemented with 100 mM chlorophenol red ß-D-
galactopyranoside (CPRG; Calbiochem), incubated 12 hr, and ß-
galactosidase activity assessed by spectrophotometric determina-
tion of absorbance at 565 nm. All experiments were conducted in
triplicate, averaged, and normalized with reference to controls
exposed to neither parasites nor OVA.
In vivo assays
C57Bl/6 and Thy1.1 C57Bl/6 mice were obtained from NCI
Production and Jackson Labs, respectively; Thy1.2 OT-I TCR
transgenics were bred in an SPF facility at the University of
Pennsylvania. Thy 1.2 OT-I T-cells from pooled spleens and
lymph nodes of naı ¨ve C57Bl/6 female mice were purified on
CD3/CD28 columns, labeled 9 min in 5 mM carboxy fluoresceine
succinimidyl ester (CFSE; Molecular Probes/Invitrogen) and
transferred into congenic Thy 1.1 C57Bl/6 females animals
(5610
5 cells/mouse). After 24 hr, these animals were infected with
10
4 T. gondii parasites (RH strain or RH-OVA transgenics) with 3
mice per group. CFSE levels were determined by flow cytometry
(FACs Canto, Becton-Dickinson) at d3, 4 and 5 post-infection, in
order to assess the proliferation of OT-I cells. CD8
+ T-cell
activation was determined in parallel using antibodies against
CD62L (eBiosciences clone Mel-14), CD44 (eBioscience clone
IM7), and CD69 (eBiosciences clone H1.2F3). Data collection and
analysis was carried out using DIVA and FlowJo software. In vivo
parasite burden was tested using real-time PCR as described
previously [50]. Briefly, parasite genomic DNA was isolated using
the High Pure PCR Purification Kit (Roche) and real-time analysis
conducted using B1 primers on a 7500 Fast Real-Time PCR
System.
Statistical analysis
Student’s T tests were completed for the B3Z and flow
cytometry assays using GraphPad Prism software. P values,0.05
(*) or ,0.005 (**) are indicated.
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